ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study. (RECOVERY)

This study is currently recruiting participants.
Study NCT00509392.   Last updated on July 27, 2007.   Information provided by VNUS Medical Technologies, Inc.

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.
Official Title  Radiofrequency Endovenous ClosureFAST vs. Laser Ablation for the Treatment of Great Saphenous Reflux: A Multicenter, Single-Blinded, Randomized Study (RECOVERY)
Brief Summary

The objective of this post-market study is to compare the post-procedure recovery between two types of minimally invasive catheter treatments for venous disease in the Great Saphenous Vein.

Detailed Description
Study Phase Phase IV
Study Type  Interventional
Study Design  Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Primary Outcome Measure  Post-procedure recovery for each treatment group; including post-procedure pain and return to normal activities. [ Time Frame: 30 days following treatment. ]
Secondary Outcome Measure 
Condition  Great Saphenous Vein Disease
Venous Reflux
Intervention  Device: Segmental RF ablation with the ClosureFAST catheter
Device: Endovenous Laser
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  100
Start Date  March 2007
Completion Date November 2007
Eligibility Criteria 

Inclusion Criteria:

  • All subjects must provide written informed consent.
  • Must be a candidate for either treatment with RFA or endovenous laser.

Exclusion Criteria:

  • Subjects who require additional treatments in either leg within 30 days before or after the study procedure.
  • Subjects who are participating in another investigational study.
Gender Both
Ages 18 Years to 80 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Gary Heinemann     408-360-7274     gheinemann@vnus.com    
Contact: Susan Miksad     408-360-7325     smiksad@vnus.com    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00509392
Organization ID CVL-06-03
Secondary IDs ††
Study Sponsor  VNUS Medical Technologies, Inc.
Collaborators ††
Investigators 
Study Director:     Lian Cunningham, MD     VNUS Medical Technologies, Inc.    
Information Provided By VNUS Medical Technologies, Inc.
Verification Date July 2007
First Received Date  July 27, 2007
Last Updated Date July 27, 2007

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers